Stockholders' Equity - Additional Information (Detail) - USD ($)
|
|
|
|
|
|
|
|
1 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
Feb. 11, 2019 |
Jan. 01, 2019 |
Jul. 03, 2018 |
Apr. 05, 2018 |
Jan. 01, 2018 |
Nov. 30, 2017 |
Sep. 30, 2015 |
Nov. 30, 2019 |
Apr. 30, 2019 |
Mar. 31, 2018 |
Nov. 30, 2017 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Aug. 16, 2019 |
Jul. 23, 2019 |
Mar. 29, 2019 |
Jul. 13, 2018 |
Jun. 30, 2018 |
Dec. 31, 2017 |
Dec. 15, 2017 |
Oct. 26, 2017 |
Dec. 31, 2016 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based compensation, authorized number of shares |
|
|
|
|
|
|
|
|
|
|
|
13,750,535
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
$ 13,188,000
|
$ 15,012,000
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
$ 13,188,000
|
$ 15,012,000
|
|
|
|
|
|
|
|
|
|
Common Stock, Par or Stated Value Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
Share Price |
|
|
$ 3.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Exercise Price of Warrants or Rights |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.47
|
|
|
|
|
|
|
Stock Issued During Period, Value, Issued for Services |
|
|
|
|
|
|
$ 600,000
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross |
|
|
|
|
|
|
|
|
|
|
|
125,000
|
|
|
|
|
|
|
|
|
|
|
Capital Units, Authorized |
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
$ 13,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options |
|
|
|
|
|
|
|
|
|
|
|
$ 11,900,000
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized |
|
|
|
|
|
|
|
|
|
|
|
|
7,700,000
|
|
|
|
|
|
|
|
|
|
Share-based Compensation |
|
|
|
|
|
|
|
|
|
|
|
$ 13,188,000
|
$ 15,012,000
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
164,473
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
|
|
|
|
|
|
|
|
|
|
|
290,000
|
490,000
|
|
|
|
|
|
|
|
|
|
Payments of Stock Issuance Costs |
|
|
|
|
|
|
|
|
|
$ 41,400,000
|
|
$ 578,000
|
$ 0
|
|
|
|
|
|
|
|
|
|
Adjustments To Additional Paid In Capital At Market Offering Costs |
|
|
|
|
|
|
|
|
|
|
|
$ 1,800,000
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Outstanding |
|
|
|
|
|
|
|
|
|
|
|
1,341,167
|
1,000,000
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Authorized |
|
|
|
|
|
|
|
|
|
|
|
15,000,000
|
15,000,000
|
|
|
|
|
|
|
|
|
|
Preferred Stock, par value |
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Value, Issued |
|
|
|
|
|
|
|
|
|
|
|
$ 1,000
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Issued |
|
|
|
|
|
|
|
|
|
|
|
1,341,167
|
1,000,000
|
|
|
|
|
|
|
|
|
|
Dividends Payable, Amount Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.5839375
|
|
|
|
Preferred Stock, Liquidation Preference Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 25.00
|
$ 25.00
|
|
|
|
|
|
|
|
|
|
Proceeds from Issuance of Preferred Stock and Preference Stock |
|
|
|
|
|
|
|
|
|
|
|
$ 6,038,000
|
$ 154,000
|
|
|
|
|
|
|
|
|
|
Payments for Fees |
|
|
|
|
|
$ 100,000
|
|
|
|
|
$ 2,100,000
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of Placement of Agent Fee |
|
|
|
|
|
|
|
|
|
|
3.00%
|
1.00%
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Shares, Outstanding |
|
|
|
|
|
|
|
|
|
|
|
74,027,425
|
57,845,447
|
|
|
|
|
|
|
|
|
|
Common Stock, Value, Issued |
|
|
|
|
|
|
|
|
|
|
|
$ 74,000
|
$ 58,000
|
|
|
|
|
|
|
|
|
|
Revenue from Contract with Customer, Including Assessed Tax |
|
|
|
|
|
|
|
|
|
|
|
$ 34,921,000
|
$ 23,376,000
|
|
|
|
|
|
|
|
|
|
Common Stock, Shares, Issued |
|
|
|
|
|
|
|
|
|
|
|
74,027,425
|
57,845,447
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Preferred Stock, At The Market Offering |
|
|
|
|
|
|
|
|
|
|
|
$ 812,000
|
$ 0
|
|
|
|
|
|
|
|
|
|
Common Stock Shares Available For Future Issuance Value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 38,300,000
|
|
|
|
|
|
|
|
Long-term incentive plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash bonus |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
Employee Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Stock Purchase Plan to eligible employees, Reckoning fair value percentage during offering period |
|
|
|
|
|
|
|
|
|
|
|
85.00%
|
|
|
|
|
|
|
|
|
|
|
Common Stock issued in connection with the first ESPP offering |
|
|
|
|
|
|
|
|
|
|
|
454,515
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
$ 100,000
|
$ 200,000
|
|
|
|
|
|
|
|
|
|
Common Stock, Capital Shares Reserved for Future Issuance |
|
|
|
|
|
|
|
|
|
|
|
545,485
|
|
|
|
|
|
|
|
|
|
|
Plan 2013 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based compensation, authorized number of shares |
|
|
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
|
|
|
|
|
|
|
|
Revenue from Contract with Customer, Including Assessed Tax |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
|
|
|
Plan 2007 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based compensation, authorized number of shares |
|
|
|
|
|
|
|
|
|
|
|
|
6,000,000
|
|
|
|
|
|
|
|
|
|
Longterm Incentive Program [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000
|
$ 1,300,000
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value |
|
|
|
|
|
|
|
|
|
|
|
$ 600,000
|
2,300,000
|
|
|
|
|
|
|
|
|
|
Capital Units, Authorized |
|
|
|
|
|
|
|
|
|
|
|
100,000,000
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation |
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000
|
$ 1,300,000
|
|
|
|
|
|
|
|
|
|
Plan 2017 and 2013 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based compensation, shares available for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,000,000
|
Plan 2007 And 2013 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Based compensation, shares available for issuance |
|
|
|
|
|
|
|
|
|
|
|
2,249,465
|
|
|
|
|
|
|
|
|
|
|
Series A Preferred Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Issued, Price Per Share |
|
|
|
|
|
$ 25.00
|
|
|
|
|
$ 25.00
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Shares Authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
Preferred Stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
Preferred Stock, Dividend Rate, Percentage |
|
|
|
|
|
|
|
|
|
|
|
9.375%
|
|
|
|
|
|
|
|
|
|
|
Dividends Payable, Amount Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.299479
|
$ 2.34375
|
|
|
Preferred Stock, Liquidation Preference Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 25.00
|
|
|
|
|
|
|
|
|
|
|
Issuance Of Preferred Stock For At Market Offering, In Shares |
|
|
|
|
|
|
|
|
|
|
|
39,292
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock issued in connection with the first ESPP offering |
|
|
|
|
|
|
|
|
|
|
|
98,007
|
110,856
|
|
|
|
|
|
|
|
|
|
Shares Issued, Price Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 1.88
|
$ 2.50
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares |
|
|
|
|
|
|
|
|
|
|
|
11,798,468
|
2,914,410
|
|
|
|
|
|
|
|
|
|
Adjustments To Additional Paid In Capital At Market Offering Costs |
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
$ 300,000
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 15,100,000
|
$ 7,300,000
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares |
|
|
|
|
|
|
|
|
|
|
|
8,000,000
|
2,900,000
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | 2019 At The Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 5,600,000
|
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares |
|
|
|
|
|
|
|
|
|
|
|
3,800,000
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 1.49
|
|
|
|
|
|
|
|
|
|
|
Agents Commission, Percentage |
|
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
Payments for Commissions |
|
|
|
|
|
|
|
|
|
|
|
$ 200,000
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] | IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|
|
|
|
|
|
|
39,375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Dividend Rate, Percentage |
|
|
|
|
|
|
|
9.375%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share |
|
|
|
|
|
|
|
$ 20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance Of Preferred Stock For Public Offering |
|
|
|
|
|
|
|
262,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional shares |
|
|
|
|
|
|
|
39,375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of preferred stock |
|
|
|
|
|
|
|
$ 6,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] | 2018 Preferred ATM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Dividend Rate, Percentage |
|
|
|
9.375%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance Of Preferred Stock For At Market Offering, In Shares |
|
|
|
|
|
|
|
|
|
|
|
39,292
|
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Preferred Stock, At The Market Offering |
|
|
|
|
|
|
|
|
|
|
|
$ 800,000
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 20.67
|
|
|
|
|
|
|
|
|
|
|
Agents Commission, Percentage |
|
|
|
|
|
|
|
|
|
|
|
7.00%
|
|
|
|
|
|
|
|
|
|
|
Payments for Commissions |
|
|
|
|
|
|
|
|
|
|
|
$ 24,000
|
|
|
|
|
|
|
|
|
|
|
Senior Vice President [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, Issued for Services |
|
|
|
|
|
|
|
|
|
|
|
2,600,000
|
$ 2,300,000
|
|
|
|
|
|
|
|
|
|
Mustang Bio, Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Shares Available For Future Issuance Value |
|
|
|
|
|
|
|
|
|
|
|
20,900,000
|
|
|
|
|
|
|
|
|
|
|
Marketable Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 75,000,000
|
|
|
$ 75,000,000
|
|
|
|
|
|
Mustang Bio, Inc [Member] | Common Stock [Member] | Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
|
|
|
|
|
|
|
|
|
|
|
$ 22,500,000
|
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares |
|
|
|
|
|
|
|
|
|
|
|
3,500,000
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share |
|
|
|
|
|
|
|
|
|
|
|
$ 6.42
|
|
|
|
|
|
|
|
|
|
|
Agents Commission, Percentage |
|
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Common Stock Net of Issuance Costs |
|
|
|
|
|
|
|
|
|
|
|
$ 22,000,000
|
|
|
|
|
|
|
|
|
|
|
Mustang Bio, Inc [Member] | Common Stock [Member] | IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|
|
|
|
|
|
|
|
1,031,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
|
|
|
|
|
|
$ 6,875,000
|
|
$ 31,600,000
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share |
|
|
|
|
|
|
|
|
$ 4.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional shares |
|
|
|
|
|
|
|
|
1,031,250
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Common Stock Net of Issuance Costs |
|
|
|
|
|
|
|
|
$ 29,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Checkpoint [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Issued, Price Per Share |
|
|
|
|
|
|
|
|
|
$ 4.35
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
|
|
|
|
|
|
|
$ 19,600,000
|
|
$ 20,800,000
|
|
$ 8,000,000
|
$ 8,000,000
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues |
|
|
|
|
|
|
|
15,400,000
|
|
5,290,000
|
|
2,273,189
|
1,841,774
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, New Issues |
|
|
|
|
|
|
|
|
|
$ 23,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments of Stock Issuance Costs |
|
|
|
|
|
|
|
|
|
$ 2,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Maximum Authorized Amount Of Shares To Be Sold |
|
|
|
|
|
$ 100,000,000
|
|
|
|
|
$ 100,000,000
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share |
|
|
|
|
|
|
|
$ 1.27
|
|
|
|
$ 3.52
|
$ 4.33
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Common Stock Net of Issuance Costs |
|
|
|
|
|
|
|
$ 17,600,000
|
|
|
|
$ 7,800,000
|
$ 7,700,000
|
|
|
|
|
|
|
|
|
|
Underwriting Discounts And Offering Expenses |
|
|
|
|
|
|
|
$ 2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dr Rosenwald [Member] | Longterm Incentive Program [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
|
648,204
|
|
|
586,429
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and Development Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
2,800,000
|
5,300,000
|
|
|
|
|
|
|
|
|
|
General and Administrative Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
10,400,000
|
9,700,000
|
|
|
|
|
|
|
|
|
|
Restricted Stock Awards and Restricted Stock Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation |
|
|
|
|
|
|
|
|
|
|
|
$ 11,500,000
|
$ 13,900,000
|
|
|
|
|
|
|
|
|
|
Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred Compensation Arrangement with Individual, Shares Issued |
|
|
|
|
|
|
|
|
|
|
|
230,000
|
230,000
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value |
|
|
|
|
|
|
|
|
|
|
|
$ 1,400,000
|
$ 6,600,000
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
|
|
|
|
|
|
|
|
|
|
|
1,546,408
|
1,721,802
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Value, Restricted Stock Award, Gross |
|
|
|
|
|
|
|
|
|
|
|
$ 2,000,000
|
$ 3,300,000
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value |
|
|
|
|
|
|
|
|
|
|
|
$ 400,000
|
1,800,000
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
|
|
|
|
|
|
|
|
|
|
|
227,083
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] | Maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition |
|
|
|
|
|
|
|
|
|
|
|
4 years 9 months 18 days
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] | Minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition |
|
|
|
|
|
|
|
|
|
|
|
2 years 1 month 6 days
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] | Mustang Bio, Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments To Additional Paid In Capital At Market Offering Costs |
|
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Awards [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period |
|
|
|
|
|
|
|
|
|
|
|
395,869
|
|
|
|
|
|
|
|
|
|
|
Options to Purchase Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
100,000
|
|
|
|
|
|
|
|
|
|
Share-based Compensation |
|
|
|
|
|
|
|
|
|
|
|
$ 300,000
|
$ 100,000
|
|
|
|
|
|
|
|
|
|